Rhumbline Advisers Verastem, Inc. Transaction History

Rhumbline Advisers

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.02 - $1.83 $170,781 - $306,402	-167,433 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.06 - $2.1 $497 - $984	469 Added 0.28%	167,433 $236,000
Q4 2021 Feb 10, 2022	SELL	$2.05 - $3.2 $6,707 - $10,470	-3,272 Reduced 1.92%	166,964 $342,000
Q3 2021 Nov 12, 2021	BUY	$2.54 - $4.07 $17,211 - $27,578	6,776 Added 4.15%	170,236 $524,000
Q2 2021 Aug 05, 2021	SELL	$2.57 - $4.85 $97,079 - $183,203	-37,774 Reduced 18.77%	163,460 $665,000
Q1 2021 May 06, 2021	SELL	$1.9 - $2.82 $17,822 - $26,451	-9,380 Reduced 4.45%	201,234 $497,000
Q4 2020 Feb 10, 2021	BUY	$1.15 - $2.4 $36,122 - $75,386	31,411 Added 17.53%	210,614 $449,000
Q3 2020 Nov 12, 2020	SELL	$1.11 - $1.68 $33,455 - $50,635	-30,140 Reduced 14.4%	179,203 $217,000
Q2 2020 Aug 13, 2020	BUY	$1.69 - $4.2 $353,789 - $879,240	209,343 New	209,343 $360,000
Q2 2019 Aug 14, 2019	SELL	$1.25 - $3.14 $138,516 - $347,952	-110,813 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$2.79 - $4.09 $64,170 - $94,070	23,000 Added 26.19%	110,813 $328,000
Q4 2018 Jan 31, 2019	BUY	$3.23 - $7.01 $100,259 - $217,590	31,040 Added 54.67%	87,813 $295,000
Q3 2018 Nov 07, 2018	BUY	$6.86 - $9.97 $46,462 - $67,526	6,773 Added 13.55%	56,773 $412,000
Q2 2018 Aug 06, 2018	BUY	$2.88 - $8.67 $144,000 - $433,500	50,000 New	50,000 $344,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.